Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001636587-25-000007·ACORN BIOVENTURES, L.P.
Schedule 13G ownership disclosure
Puma Biotechnology Inc
Common Stock, $0.0001 par value per share · CUSIP: 74587V107
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ACORN BIOVENTURES, L.P.
Shares: 1,654,823.00 · Class: 3.3%
- ACORN BIOVENTURES 2, L.P.
Shares: 2,285,229.00 · Class: 4.7%
- ACORN CAPITAL ADVISORS GP, LLC
Shares: 1,654,823.00 · Class: 3.3%
- Anders Hove
Shares: 3,940,052.00 · Class: 8.0%
- Acorn Capital Advisors GP 2, LLC
Shares: 285,229.00 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001636587-25-000007
- Form type
- SCHEDULE 13G/A
- Filer
- ACORN BIOVENTURES, L.P.
- CIK
- CIK 1766853
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership